| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.7 | $0-$5k | 0.00 |
Summary
A vulnerability described as problematic has been identified in ArbitroWeb 0.5/0.6. Affected is an unknown function. Such manipulation of the argument rawURL leads to cross site scripting. This vulnerability is listed as CVE-2004-0617. The attack may be performed from remote. In addition, an exploit is available.
Details
A vulnerability, which was classified as critical, has been found in ArbitroWeb 0.5/0.6. Affected by this issue is an unknown code block. The manipulation of the argument rawURL with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-80. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages. Impacted is confidentiality, integrity, and availability. CVE summarizes:
Cross-site scripting (XSS) vulnerability in ArbitroWeb 0.6 allows remote attackers to inject arbitrary script or HTML via the rawURL parameter.
The weakness was presented 12/06/2004 by Josh Gilmour (Website). The advisory is available at marc.theaimsgroup.com. This vulnerability is handled as CVE-2004-0617 since 06/29/2004. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. Technical details as well as a public exploit are known. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
The exploit is available at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (16481), Exploit-DB (24231) and SecurityFocus (BID 10592†). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 5.7
VulDB Base Score: 6.3
VulDB Temp Score: 5.7
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-80 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
06/22/2004 🔍06/29/2004 🔍
12/06/2004 🔍
12/06/2004 🔍
04/14/2015 🔍
02/09/2025 🔍
Sources
Advisory: marc.theaimsgroup.comResearcher: Josh Gilmour
Status: Not defined
CVE: CVE-2004-0617 (🔍)
GCVE (CVE): GCVE-0-2004-0617
GCVE (VulDB): GCVE-100-22538
X-Force: 16481 - ArbitroWeb rawURL cross-site scripting
SecurityFocus: 10592 - ArbitroWeb PHP Proxy Cross-Site Scripting Vulnerability
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 04/14/2015 13:25Updated: 02/09/2025 09:05
Changes: 04/14/2015 13:25 (46), 06/22/2018 07:47 (7), 02/09/2025 09:05 (27)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.